Can personalized nutrition slow kidney decline? new study investigates
NCT ID NCT07245186
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 1,800 adults with reduced kidney function (not on dialysis) to see how nutrition and lifestyle affect their health. Researchers will track changes in kidney function, heart health, bone health, and thinking skills over time. The goal is to find better ways to manage chronic kidney disease early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,800 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2021
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults aged 18 years or older with reduced kidney function (eGFR \< 90 mL/min/1.73 m²) who are not receiving dialysis. Participants are recruited from outpatient clinics at Huashan Hospital, Fudan University.
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Non-dialysis patients with chronic kidney disease (CKD) stages 1-5. 2. Aged 18 to 90 years, no restriction on gender. 3. Sufficient health literacy or a family member with adequate literacy to comply with dietary diary recording and other study procedures. 4. Stable primary disease of CKD at the time of enrollment. Exclusion Criteria: 1. Patients with malignancies, severe cardiovascular diseases, osteoporosis, or severe hematological disorders. 2. Active infections (CRP \>10 mg/L) or current use of nephrotoxic drugs. 3. Limb paralysis or amputation. 4. Use of immunosuppressants (cyclosporine, tacrolimus) within the past 3 months or steroid therapy equivalent to prednisone \>10 mg/day. 5. Severe gastrointestinal diseases affecting nutrient absorption. 6. Participation in other diet- or drug-related clinical studies within the past month or ongoing. 7. Any other condition deemed inappropriate for participation by the investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD-MBD - chronic kidney disease mineral and bone disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Huashan hospital, Fudan university
Shanghai, Shanghai Municipality, 20040, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Four-Part check may reveal hidden malnutrition in sickest kids
- Can protein shakes help older veterans bounce back after surgery?
- Why do some malnourished infants recover and others Don't? hospitals track every gram
- Can olive oil and exercise keep older adults on their feet?
- Can a Hands-On reflex therapy steady an older Person's stance?
- Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?